Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patientsSamantha Pozzi, On behalf of the Gruppo Italiano St, Raffaella Marcheselli et al.|Leukemia & lymphoma/Leukemia and lymphoma|2006Cited by 93
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA studyIdanna Innocenti, Luca Laurenti, Gianluigi Reda et al.|Haematologica|2022Cited by 20
Mycosis fungoides: disease evolution of the "lion queen" revisited.Pietro Quaglino, Mg Bernengo, Ugo Bottoni et al.|PubMed|2012Cited by 12
A Snapshot of the Management of Chronic Lymphocytic Leukemia in Italy. Preliminary Analysis on over 3000 Patients Enrolled in the Gimema CLL2121 TrialLydia Scarfò, Paolo Ghia, Marta Coscia et al.|Blood|2023Cited by 1
Baseline Characteristics from CLL-ZANU2024, an Italian Non-Interventional Study Assessing the Real-World Use of Zanubrutinib in the Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)Enrica Antonia Martino, Federico Vozzella, Raffaella Pasquale et al.|Blood|2024Cited by 0